Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome

FEMS Microbiology Letters

Volumn 192, Issue 1, 2000, Pages 1-7

  Yarwood, Jeremy M ^a   Leung, Donald Y M ^b   Schlievert, Patrick M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Atopic dermatitis; Kawasaki syndrome; Psoriasis; Staphylococcus aureus; Streptococcus pyogenes; Superantigen

Indexed keywords

BACTERIAL TOXIN; IMMUNOGLOBULIN E; SUPERANTIGEN;

ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; HUMAN; IMMUNOREACTIVITY; KERATINOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PSORIASIS; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 0034333382     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(00)00400-6     Document Type: Short Survey

References (41)

1. Bacterial superantigens induce T-cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production
2. Skin innate immune system in psoriasis: friend or foe? [comment]
3. The role of bacterial superantigens in psoriasis and atopic dermatitis
4. Dermal injection of immunocytes induces psoriasis
5. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis
6. The role of streptococcal infection in the initiation of guttate psoriasis
7. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis
8. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T-cells that cross-react with keratin?
9. Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococcal antigens
10. Selective induction of rheumatoid factors by superantigens and human helper T-cells
11. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis
12. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-α from human keratinocytes
13. Atopic dermatitis: new insights and opportunities for therapeutic intervention
14. Staphylococcus aureus in the lesions of atopic dermatitis
15. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis
16. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis
17. Evidence for a disease promoting effect of S. aureus-derived exotoxins in atopic dermatitis
18. Application of staphylococcal enterotoxin B on normal and atopic skin induces upregulation of T-cells via a superantigen-mediated mechanism
19. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens
20. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis
21. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen
22. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
23. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions
24. Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T-cell-dependent inflammatory response
25. Th2 cells mediate IL-4-dependent local tissue inflammation
26. Evidence for superantigen involvement in skin homing of T-cells in atopic dermatitis
27. Heterogeneity in Kawasaki syndrome
28. Superantigens, conventional antigens and the etiology of Kawasaki syndrome
29. Evidence for a superantigen mediated process in Kawasaki disease [see comments]
30. Selective expansion of T-cells expressing Vβ2 in toxic shock syndrome
31. Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A
32. Toxic shock syndrome in children aged 10 years or less
33. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male [see comments]
34. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome
35. Association of toxic shock syndrome toxin- and exoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease
36. Mechanisms of immunoglobulin action: observations on Kawasaki syndrome and RSV prophylaxis
37. The etiology of Kawasaki disease: superantigen or conventional antigen?
38. + T-cells in Kawasaki disease
39. Anti-human cardiac myosin autoantibodies in Kawasaki syndrome
40. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by γ interferon
41. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome